Oncotarget

Corrections:

Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice

PDF  |  How to cite

Oncotarget. 2018; 9:25750-25750. https://doi.org/10.18632/oncotarget.22813

Metrics: PDF 871 views  |   ?  

Haobin Cai2,1, Yijie Wang1, Jiayang He1, Tiantian Cai1, Jun Wu1, Jiansong Fang1, Rong Zhang1, Zhouke Guo2, Li Guan1, Qinkai Zhan1, Li Lin3, Yao Xiao4, Huafeng Pan1 and Qi Wang1

1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
2Department of Neurology & Psychology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen 518033, China
3Guangzhou University of Chinese Medicine, Guangzhou 510405, China
4Guangzhou Medical University, Guangzhou 510182, China

Published: May 22, 2018

This article has been corrected: The correct 2nd affiliation and author name is given below:

Haobin Cai2,1

2Department of Neurology & Psychology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen 518033, China

Original article: Oncotarget. 2017; 8:92621-92634. DOI: https://doi.org/10.18632/oncotarget.21515.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22813